We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NTRS:NASDAQNorthern Trust Corporation Analysis

Data as of 2026-09-04 - not real-time

$187.45

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Northern Trust Corporation is priced at $187.44 and its moving averages line up in bullish order, the shorter sitting above the longer. It has gained 5.3% over the past 30 days. With RSI at 54.7 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $181.71 up to resistance at $195.78.
Valuation screens as fair: a P/E of 15.8 sits in line with the sector average of 16.6. Revenue is growing at 36.4% on a 24.7% profit margin. The 1.78% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 19.1%, a beta of 0.95 and a maximum drawdown of 12.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.

Top Market Events

Financial services company Northern Trust NASDAQ:NTRS reported Q2 CY2026 results , with sales up 35.Seeking Alpha1monRBC Capital downgrades Northern Trust to Hold-equivalent after Q2 earningsNorthern Trust NTRS was cut...Yahoo Finance1monNorthern Trust Corp NTRS Q2 2026 Earnings Call Highlights: Robust Revenue Growth and .

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 158.16
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 15.8 versus sector average of 16.6
  • Trading above the 200-day average of 158.16

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 15.8 versus sector average of 16.6
  • Profit margin of 24.7% is healthy
  • Revenue growth of +36.4%

Key Metrics & Analysis

Financial Health

Revenue Growth36.40%
Profit Margin24.67%
P/E Ratio15.8
ROE17.07%
ROA1.28%
P/B Ratio2.7
Op. Cash Flow$529.3M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI54.7
Support$181.71
Resistance$195.78
MA 20$187.10
MA 50$183.61
MA 200$158.16
MACDBearish
VolumeDecreasing
Fear & Greed Index96.05

Valuation

Fair Value$35.02
Target Price$184.27
Upside/Downside-1.69%
GradeFair
TypeBlend
Dividend Yield1.78%

Risk Assessment

Beta0.95
Volatility19.06%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.